About Us
Abogen Biosciences is a leading biotech company dedicated to bringing an array of transformative therapies through the advancement of mRNA science and technology. Through pioneering science, revolutionary technologies and unwavering commitment to patients, the company has established its own industry-leading proprietary mRNA platform and nanoparticle delivery system that enable us to deliver first approved China developed COVID mRNA vaccine in combating against the global pandemic.Currently, the company is progressing with its mature pipeline of mRNA-based therapeutics to tackle otherwise untreatable diseases in diversified therapeutic areas: infectious diseases , oncology and rare diseases.
EUA Product
Clinical-stage Candidates
R&D, Manufacturing and
Operation Sites
500 +
50 %+
With Advanced Degrees
150 +
Patents Filed
"As of 2023 Q1, covering all Abogen entities"
XML 地图